Login to Your Account



Search

Search results

Clinic roundup

Pacira Pharmaceuticals Inc. announced additional phase III data supporting the safety and efficacy of (bupivacaine liposome injectable suspension) to achieve a femoral nerve block in patients undergoing total knee arthroplasty. (BioWorld-To ...

BioWorld Today - Staff - 2014-04-07 23:00 - 0 comments - 0 attachments

Clinic roundup

Noxxon Pharma AG , of Berlin, said phase IIa proof-of-concept data from the emapticap pegol (NOX-E36) trial in diabetic nephropathy were presented at the ISN Nexus Symposium in Bergamo, Italy. (BioWorld-Today-2014-04-07) ...

BioWorld Today - Staff - 2014-04-06 23:00 - 0 comments - 0 attachments

Clinic roundup

Gilead Sciences Inc. , of Foster City Calif., said positive top-line results from a phase III trial evaluating Sovaldi (sofosbuvir) in combination with ribavirin for the treatment of genotype 2 chronic hepatitis C virus (HCV) infection in Japan put i ...

BioWorld Today - Staff - 2014-04-03 23:00 - 0 comments - 0 attachments

Pharma: Clinic roundup

Dompe Group , of Milan, said it started a phase Ib/II study to assess the safety and potential efficacy of recombinant human nerve growth factor (rhNGF) eye drops in two doses vs. placebo. (BioWorld-Today-2014-04-04) ...

BioWorld Today - Staff - 2014-04-03 23:00 - 0 comments - 0 attachments

Pharma: Clinic roundup

Bayer HealthCare Pharmaceuticals Inc. , of Whippany, N.J., began enrollment in a trial studying Xofigo (radium Ra 223 dichloride) injection in combination with abiraterone acetate and prednisone/prednisolone for the treatment of asymptomatic or mil ...

BioWorld Today - Staff - 2014-04-02 23:00 - 0 comments - 0 attachments

Clinic roundup

Cardiocell LLC , of San Diego, received investigational new drug approval from the FDA for a phase IIa study using its allogeneic stem cell therapy to treat patients with chronic heart failure (CHF). (BioWorld-Today-2014-04-03) ...

BioWorld Today - Staff - 2014-04-02 23:00 - 0 comments - 0 attachments

Clinic roundup

Galectin Therapeutics Inc. , of Norcross, Ga., said results from the first cohort of its phase I trial showed that GR-MD-02 had an effect on biomarkers that suggests a therapeutic effect on fibrosis, inflammation and cellular injury. (BioWor ...

BioWorld Today - Staff - 2014-04-01 23:00 - 0 comments - 0 attachments

Pharma: clinic roundup

Forest Laboratories Inc ., of New York, and Gedeon Richter Plc , of Budapest, Hungary, reported positive top-line results from a global, randomized, placebo-controlled, fixed-dose, eight-week phase IIb trial evaluating the efficacy and safety of c ...

BioWorld Today - Staff - 2014-03-31 23:00 - 0 comments - 0 attachments

Clinic roundup

Capricor Therapeutics Inc. , of Los Angeles, presented data at the American College of Cardiology 63rd Annual Scientific Session and Expo highlighting positive data from the phase I portion of the company’s ALLSTAR (ALLogeneic heart STem cells to Ach ...

BioWorld Today - Staff - 2014-03-31 23:00 - 0 comments - 0 attachments

Clinic roundup

Cytokinetics Inc. , of South San Francisco, said it began enrolling the expansion phase of COSMIC-HF (Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure). The double-blind, randomized, placebo-controlled, multicente ...

BioWorld Today - Staff - 2014-03-30 23:00 - 0 comments - 0 attachments